When CFO Brew needed expert insight into why financial leaders avoid certain language during economic uncertainty, they knew exactly who to call: our CEO, Michael Maslansky. Michael was recently quoted in this interesting article about challenging economic conditions and the dreaded “R word.”
For decades, “healthy” was one of the most powerful words in food. It sat proudly on cereal boxes, snack packs, and frozen meals. But under the Make America Healthy Again (MAHA) movement, “healthy” is suddenly a liability. And the brands who don’t evolve their language are already paying for it in lawsuits, recalls, and reputational damage. m+p Senior Vice President Jason Martuscello shares why Language Strategy matters now more than ever.
Synthetic research isn’t magic. It’s not snake oil, either. It’s a tool that can deliver insights faster, more affordably, and with audiences that were previously out of reach. But like any tool, it works best when you know how and when to use it. The research projects that will win aren’t the ones that blindly adopt AI research or stubbornly avoid it. They’re the ones that ask the right questions first.
Before you commit to synthetic research – or write it off entirely – here are five steps that will help you be successful.
There are moments in history when the ground beneath us moves and everyone feels it. Today, we’re living through one of those moments. Outrage is everywhere. It’s not just on the news or in your social feeds. It’s on the checkout line. It’s at the customer service desk. People aren’t simply disappointed. They’re angry. And the target of that anger is no longer just politicians or Wall Street “fat cats.” It’s any company, in any industry, that fails to measure up to a new, higher standard: fairness. Our latest research reveals three seismic shifts you need to know about what Americans expect from the companies they do business with.
When Zoe Glass was offered an intern position with us at m+p, she set out on a journey to understand what Language Strategy is all about. Here, she reflects on Stuart Hall, Kelly Osbourne, and what she learned about Language Strategy.
If you’re in pharma communications and you think you’re in the business of “building trust,” you’re already behind. The rules have changed. And the stakes have never been higher. Lee Carter offers a wake-up call for those in pharma comms… and five key shifts to make to resonate with patients today.
Consumer rage is surging. Customers feel betrayed–and people are reaching a breaking point. Across the country, once-trusted brands are raising prices, shrinking products, and making customer service harder to access. Playing short-term games with customer trust is a dangerous gamble. Michael Maslansky shares three principles to help companies do better by treating customers fairly.
News that RFK Jr. will push to change the childhood vaccine schedule is putting intense new scrutiny on recommendations. When pharma responds with “trust the science” or appeals to authority of the CDC’s past recommendations, these messages often fall flat—or worse, appear dismissive.
Does your company have a corporate narrative? Do you know it? Can people find it? And more importantly, is it the right one? Ben Feller suggests it may be time to see if your narrative is doing its job–and offers three ways to simplify the challenge of finding the right one.
The Make America Healthy Again (MAHA) Commission has dropped its roadmap, and while the headlines sound like the usual policy fare (“modernize vaccines,” “expand injury research,” “re-evaluate childhood schedules”), what’s really happening is a communications earthquake. Ignore it, and you do so at your own peril.
